Sanjeev Raghuwanshi (S Raghuwanshi)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Cell death discovery

Research square

Blood cancer journal

Journal of cellular physiology

Jiwaji University (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Jiwaji University Jul 01 2009 - Jun 25 2011

India

MSC :: Biotechnology

Jiwaji University Jul 01 2006 - Jun 15 2009

India

BSC :: Biotechnology

Publications

Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Hisham Mohammed, Z Wang, Alexander Domling, Carlos Jaime Camacho, Andrei L Gartel
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies. Cell death discovery 10 (1) (2024)
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Hisham Mohammed, Z Wang, Alexander Domling, Carlos Jaime Camacho, Andrei L Gartel
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies. Cell death discovery 10 (1) (2024)
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Hisham Mohammed, Z Wang, Alexander Domling, Carlos Jaime Camacho, Andrei L Gartel
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies. Cell death discovery 10 (1) (2024)
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Hisham Mohammed, Z Wang, Alexander Domling, Carlos Jaime Camacho, Andrei L Gartel
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies. Cell death discovery 10 (1) (2024)
Andrei L Gartel, Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Zefeng Wang, Alex Domling, Carlos Jaime Camacho
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies. Research square (2023)
Irum Khan, A Kaempf, Sanjeev Raghuwanshi, Mikhail S Chesnokov, X Zhang, Z Wang, A Domling, Jeffrey W Tyner, C Camacho, Andrei L Gartel
Favorable outcomes of NPM1 mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance. Blood cancer journal 13 (1) (2023)
Sanjeev Raghuwanshi, Swati Dahariya, Durga Shankar Sharma, Narasaiah Kovuru, Itishri Sahu, Ravi Kumar Gutti
RUNX1 and TGF-β signaling cross talk regulates Ca2+ ion channels expression and activity during megakaryocyte development. The FEBS journal 287 (24) (2020)
Durga Shankar Sharma, Sanjeev Raghuwanshi, Narasaiah Kovuru, Swati Dahariya, Dushyant Kumar Gautam, Indira Paddibhatla, Ravi Kumar Gutti
Virodhamine, an endocannabinoid, induces megakaryocyte differentiation by regulating MAPK activity and function of mitochondria. Journal of cellular physiology 236 (2) (2020)

Sanjeev Raghuwanshi.css-eqlu8i{font-size:small;padding-left:4px;} (S Raghuwanshi)

Publication Activity (10 Years)

Top Topics

Top Venues

Sanjeev Raghuwanshi (S Raghuwanshi)